Position in MRK
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$10,230,784
+$1,126,395 QoQ
Shares Held
79,617
+5.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#736
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $186,163,406 across 16 Drug Manufacturers - General names. MRK ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
68,190 | $81,789,138 | |
| 2 | JNJ |
Johnson & Johnson
|
89,403 | $22,705,679 | |
| 3 | AMGN |
Amgen Inc
|
51,552 | $18,668,010 | |
| 4 | ABBV |
AbbVie Inc.
|
62,909 | $15,830,420 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
79,617 | $10,230,784 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
66,482 | $8,399,335 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
115,747 | $6,669,342 | |
| 8 | NVS |
Novartis AG
|
39,351 | $6,167,088 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,230,784 | 79,617 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $9,104,389 | 75,687 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $8,149,018 | 77,418 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $5,320,070 | 63,387 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $6,017,510 | 67,040 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,028,063 | 70,648 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $7,844,157 | 69,075 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $8,909,886 | 71,970 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $6,735,123 | 51,043 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $5,303,277 | 48,645 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $3,368,832 | 32,723 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $3,644,131 | 31,581 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,131,589 | 29,435 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $3,184,486 | 28,702 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $2,287,433 | 26,561 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,340,060 | 25,667 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $2,023,188 | 24,658 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $1,768,851 | 23,080 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $2,647,402 | 35,247 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $2,744,036 | 35,284 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,335,134 | 30,291 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,070,116 | 37,532 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $2,801,471 | 33,773 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $2,663,169 | 34,439 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,351,285 | 30,560 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||